This new type of vaccine, which is based on the same technology as the Covid vaccines first developed by BioNTech and Moderna, is seen by many as a potential breakthrough in the fight against cancer.

Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...

A medical worker prepares a dose of the Pfizer-Bivalent coronavirus disease (COVID-19) vaccine. (Eric Gaillard/Reuters) ...

Imagine if antibodies, hormones for fertility, proteins like insulin, and vaccines could be swallowed instead of taken by ...

Under normal circumstances, the study of health problems after COVID vaccinations posted online ... defined by the researchers as “post vaccine syndrome,” or PVS. “This study is early ...

This page is no longer being updated and reflects the status of vaccine progress through March 4, 2021. For more coverage about the pandemic, visit our coronavirus hub. 3 vaccineshave been ...

Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and more. Jessica was a writer on the Wellness team, with a focus on health ...

From going to the movies and performing arts to the gym and home office, here's how San Antonio spaces have changed since the ...

Yale researchers have found "differences in immune profiles" among those who struggle with negative reactions to the Covid vaccine Spencer Platt/Getty Scientists are trying to understand why a ...

Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

For a majority of people, the COVID vaccine doesn’t cause adverse health effects — but a small percentage experience chronic symptoms that can last for months or even years. Yale researchers ...

Nanotechnology is being hailed as the next medical revolution, promising everything from precision drug delivery to real-time ...